Dysregulated chemokine receptor expression and chemokine-mediated cell trafficking in pediatric patients with ESRD

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 2, 2008, Pages 397-406

  Sherry, Barbara ^a,b   Dai, Wei Wei ^a   Lesser, Martin L ^a   Trachtman, Howard ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b North Shore University Hospital of the North Shore LIJ Health System ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCR2 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR1; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BIOSYNTHESIS; BLOOD; CHILD; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; MONOCYTE; NEUTROPHIL; PRESCHOOL CHILD; PROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; MALE; MONOCYTES; NEUTROPHILS; PROSPECTIVE STUDIES; RECEPTORS, CCR2; RECEPTORS, INTERLEUKIN-8A;

EID: 42549117981     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00120107     Document Type: Article

References (48)

1. Marr KA, Kong L, Fowler VG, Gopal A, Sexton DJ, Conlon PJ, Corey GR: Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 54: 1684-1689, 1998
2. Liangos O, Gul A, Madias NE, Jaber BL: Long-term management of the tunneled venous catheter. Semin Dial 19: 158-164, 2006
3. Beathard GA: Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10: 1045-1049, 1999
4. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M: Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies. Kidney Int 57: 2151-2155, 2000
5. Bunke CM, Brier ME, Golper TA: Outcomes of single organism peritonitis in peritoneal dialysis: Gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 52: 524-529, 1997
6. Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA: Risk of peritonitis and technique failure by CAPD connection technique: A national study. Kidney Int 42: 967-974, 1992
7. Ruiz P, Gomez F, Schreiber AD: Impaired function of macrophage Fc gamma receptors in end-stage renal disease. N Engl J Med 322: 717-722, 1990
8. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55: 97-179, 1994
9. Adrie C, Pinsky MR: The inflammatory balance in human sepsis. Intensive Care Med 26: 364-375, 2000
10. Wang JM, Sherry B, Fivash MJ, Kelvin DJ, Oppenheim JJ: Human recombinant macrophage inflammatory protein-1 alpha and -beta and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J Immunol 150: 3022-3029, 1993
11. Maus U, von Grote K, Kuziel WA, Mack M, Miller EJ, Cihak J, Stangassinger M, Maus R, Schlondorff D, Seeger W, Lohmeyer J: The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am J Respir Crit Care Med 166: 268-273, 2002
12. Kurihara T, Warr G, Loy J, Bravo R: Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186: 1757-1762, 1997
13. D'Souza CD, Cooper AM, Frank AA, Ehlers S, Turner J, Bendelac A, Orme IM: A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am J Respir Cell Mol Biol 23: 188-193, 2000
14. DiTirro J, Rhoades ER, Roberts AD, Burke JM, Mukasa A, Cooper AM, Frank AA, Born WK, Orme IM: Disruption of the cellular inflammatory response to Listeria monocytogenes infection in mice with disruptions in targeted genes. Infect Immun 66: 2284-2289, 1998
15. Lindell DM, Standiford TJ, Mancuso P, Leshen ZJ, Huffnagle GB: Macrophage inflammatory protein 1alpha/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection. Infect Immun 69: 6364-6369, 2001
16. Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J, Murphy PM: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185: 1959-1968, 1997
17. Olszewski MA, Huffnagle GB, McDonald RA, Lindell DM, Moore BB, Cook DN, Toews GB: The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol 165: 6429-6436, 2000
18. Zeng X, Moore TA, Newstead MW, Hernandez-Alcoceba R, Tsai WC, Standiford TJ: Intrapulmonary expression of macrophage inflammatory protein 1alpha (CCL3) induces neutrophil and NK cell accumulation and stimulates innate immunity in murine bacterial pneumonia. Infect Immun 71: 1306-1315, 2003
19. Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B: Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 93: 700-704, 1996
20. Cohen J: The T-test for means, F-tests on means in the analysis of variance and covariance. In: Statistical Power Analysis for the Behavioral Sciences, New York, Academic Press, 1997
21. Mantovani A, Muzio M, Garlanda C, Sozzani S, Allavena P: Macrophage control of inflammation: Negative pathways of regulation of inflammatory cytokines. Novartis Found Symp 234: 120-131; discussion 131-135: 120-131, 2001
22. Moser B, Wolf M, Walz A, Loetscher P: Chemokines: Multiple levels of leukocyte migration control. Trends Immunol 25: 75-84, 2004
23. Maus UA, Waelsch K, Kuziel WA, Delbeck T, Mack M, Blackwell TS, Christman JW, Schlondorff D, Seeger W, Lohmeyer J: Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: Role of the CCL2-CCR2 axis. J Immunol 170: 3273-3278, 2003
24. Gesualdo L, Pertosa G, Grandaliano G, Schena FP: Cytokines and bioincompatibility. Nephrol Dial Transplant 13: 1622-1626, 1998
25. Horl WH: Hemodialysis membranes: Interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol 13 [Suppl 1]: S62-S71, 2002
26. Kelley VR, Rovin BH: Chemokines: Therapeutic targets for autoimmune and inflammatory renal disease. Springer Semin Immunopathol 24: 411-4211 2003
27. Segerer S: The role of chemokines and chemokine receptors in progressive renal diseases. Am J Kidney Dis 41: S15-S18, 2003
28. Anders HJ, Vielhauer V, Schlondorff D: Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63: 401-415, 2003
29. Lin CY, Lin CC, Huang TP: Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron 63: 404-408, 1993
30. Goldstein SL, Leung JC, Silverstein DM: Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: Effect of aspirin. Clin J Am Soc Nephrol 1: 979-986, 2006
31. Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, Lau YL: Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis 194: 61-70, 2006
32. Richardson RM, Pridgen BC, Haribabu B, Ali H, Snyderman R: Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J Biol Chem 273: 23830-23836, 1998
33. Sabroe I, Williams TJ, Hebert CA, Collins PD: Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol 158: 1361-1369, 1997
34. Miyata T, Inagi R, Hong K, Iida Y, Oda O, Kinoshita T, Inoue K, Miyama A, Maeda K: Fluid-phase activation of the alternative pathway of complement by excess factor D in regularly dialyzed patients. Nephron 60: 144-149, 1992
35. Deppisch RM, Beck W, Goehl H, Ritz E: Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int [Suppl 78]: S271-S277, 2001
36. Amore A, Coppo R: Immunological basis of inflammation in dialysis. Nephrol Dial Transplant 17 [Suppl 8]: 16-24, 2002
37. Cunningham PN, Quigg RJ: Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol 16: 1214-1222, 2005
38. Helmy KY, Katschke KJ Jr, Gorgani NN, Kljavin NM, Elliott JM, Diehl L, Scales SJ, Ghilardi N, van Lookeren CM: CRIg: A macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124: 915-927, 2006
39. Allegretti M, Moriconi A, Beccari AR, Di Bitondo R, Bizzarri C, Bertini R, Colotta F: Targeting C5a: Recent advances in drug discovery. Curr Med Chem 12: 217-236, 2005
40. Khandaker MH, Xu L, Rahimpour R, Mitchell G, De Vries ME, Pickering JG, Singhal SK, Feldman RD, Kelvin DJ: CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J Immunol 161: 1930-1938, 1998
41. Khandaker MH, Mitchell G, Xu L, Andrews JD, Singh R, Leung H, Madrenas J, Ferguson SS, Feldman RD, Kelvin DJ: Metalloproteinases are involved in lipopolysaccharide-and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 93: 2173-2185, 1999
42. Sabroe I, Jones EC, Whyte MK, Dower SK: Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4. Immunology 115: 90-98, 2005
43. Franchin G, Zybarth G, Dai WW, Dubrovsky L, Reiling N, Schmidtmayerova H, Bukrinsky M, Sherry B: Lipopolysaccharide inhibits HIV-1 infection of monocyte-derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J Immunol 164: 2592-2601, 2000
44. Parker LC, Whyte MK, Vogel SN, Dower SK, Sabroe I: Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. J Immunol 172: 4977-4986, 2004
45. Ianni A, Majore S, Arzani D, Carboni I, Corbo GM, Romano-Spica V: CCR2 and CCR5 gene polymorphisms in children with recurrent respiratory infections. Respir Med 95: 430-432, 2001
46. Segerer S, Henger A, Schmid H, Kretzler M, Draganovici D, Brandt U, Noessner E, Nelson PJ, Kerjaschki D, Schlondorff D, Regele H: Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney Int 69:1765-1773, 2006
47. Rovin BH: Chemokine blockade as a therapy for renal disease. Curr Opin Nephrol Hypertens 9: 225-232, 2000
48. Segerer S, Alpers CE: Chemokines and chemokine receptors in renal pathology. Curr Opin Nephrol Hypertens 12: 243-249, 2003